Accolade
Accolade, Inc. provides personalized health and benefits solutions with a focus on improving health outcomes and reducing costs for employers and their employees. The company generates revenue by offering a platform that integrates health advocacy, navigation services, and clinical programs, typically under subscription models or service contracts with businesses and health plans.
The ten most recent trades of Accolade in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
---|---|---|---|---|
Jan 17, 2025 | Sell | $1,957,828 | 6.25% | 0.18% |
Jan 17, 2025 | Sell | $1,957,828 | 6.25% | 0.18% |
Jan 17, 2025 | Sell | $1,957,828 | 6.25% | 0.18% |
Jan 16, 2025 | Sell | $707,534 | 2.21% | 0.06% |
May 10, 2024 | Buy | $418,493 | 1.01% | 0.03% |
May 09, 2024 | Buy | $954,558 | 2.36% | 0.07% |
Dec 12, 2023 | Buy | $21,875 | 0.04% | 0.00% |
Dec 11, 2023 | Buy | $18,405 | 0.03% | 0.00% |
Dec 08, 2023 | Buy | $99,871 | 0.17% | 0.01% |
Dec 07, 2023 | Buy | $37,269 | 0.07% | 0.00% |